Details for: VITAMIN/MINERAL SUPPLEMENT MP FORMULA TAB

Product description

Product name: VITAMIN/MINERAL SUPPLEMENT MP FORMULA TAB

Company name: JAMIESON LABORATORIES LTD

DIN: 02025604

Status: Cancelled Post Market

Status date: 2001-11-26

Active ingredient(s)	Strength
ASCORBIC ACID	83.3 MG / TAB
BETA-CAROTENE	1000 UNIT / TAB
BIOTIN (YEAST)	6 MCG / TAB
CALCIUM (CALCIUM HVP CHELATE)	83.3 MG / TAB
CHOLINE BITARTRATE (YEAST)	.67 MG / TAB
CHROMIUM (CHROMIUM HVP CHELATE)	8.3 MCG / TAB
COPPER (COPPER HVP CHELATE)	.67 MG / TAB
D-ALPHA TOCOPHERYL ACID SUCCINATE	266.7 UNIT / TAB
D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)	.5 MG / TAB
D-PANTOTHENIC ACID (YEAST)	1.167 MG / TAB
FOLIC ACID (YEAST)	.067 MG / TAB
INOSITOL (YEAST)	.767 MG / TAB
IODINE (KELP)	.017 MG / TAB
IRON (IRON HVP CHELATE)	1.33 MG / TAB
MAGNESIUM (MAGNESIUM HVP CHELATE)	41.67 MG / TAB
NICOTINIC ACID (YEAST)	5 MG / TAB
SELENIUM (SELENIUM HVP CHELATE)	16.7 MCG / TAB
VITAMIN A	666.7 UNIT / TAB
VITAMIN B12 (YEAST)	.67 MCG / TAB
VITAMIN B1 (YEAST)	2 MG / TAB
VITAMIN B2 (YEAST)	.67 MG / TAB
VITAMIN B6	16.2 MG / TAB
VITAMIN B6 (YEAST)	.467 MG / TAB
VITAMIN D2	66.7 UNIT / TAB
ZINC (ZINC HVP CHELATE)	3.3 MG / TAB

Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.

For consumers

Resource	Description
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

For health care professionals

Resource	Description
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.

For researchers

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

All resources

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.

Resource	Description
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

Resource	Description
Search Clinical Information	After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.
Report a side effect	Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.
Report a serious adverse drug reaction (for hospitals)	Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.